Materials & sample preparation
Niobium grades, polymer carriers, laboratory consumables, plaques, pellets, retained samples and traceable experimental batches.
PoliNb⁴¹ is being developed to create a practical polymer delivery route for niobium. Every meaningful contribution can help fund the experiments, validation and industrial steps required to turn that thesis into a repeatable material platform.
Before a new material can reach resin producers or commercial applications, it must survive a sequence of formulation, processability, repeatability, characterization and scale-up decisions.
Niobium grades, polymer carriers, laboratory consumables, plaques, pellets, retained samples and traceable experimental batches.
Mixing, Banbury/Kneader work, DRAIS validation, milling, extrusion, pelletization, injection and associated process trials.
External testing and analytical work needed to turn observations into reproducible, decision-grade technical evidence.
Documentation, quality logic, pilot planning, manufacturing studies, IP work and the transition toward scalable production.
PoliNb⁴¹ follows a gate-based development philosophy. We avoid scaling prematurely and prioritize the experiments and evidence that determine whether the next step is justified.
Find the maximum controlled loading and the best Therpol / niobium operating window.
Repeat critical formulations with traceable records, retained samples and acceptance criteria.
Prove milling, feeding, extrusion, pelletization and thermoplastic reprocessing.
Characterize defined product-base attributes before broader host-polymer claims are pursued.
Voluntary development support is received through EVABIO entities associated with the PoliNb⁴¹ development program. Please identify the payment as “PoliNb41 Development Support” whenever the payment service allows a memo or note.
For contributions made in Brazil through the official business account.
Scan the official QR code in your eligible U.S. banking app.
For supporters who prefer an international payment platform.
Use the official EVABIO.us / @EVABIO profile or open the direct Venmo code.
Companies, foundations, laboratories and strategic organizations may prefer a documented relationship with scope, deliverables and review criteria.
Fund a defined experimental or validation objective with a mutually agreed scope.
Some of the most valuable support is not cash — it is access to the right capability at the right time.
Equity, debt, licensing, exclusivity, co-development or other economic participation belongs in a separate investment process.
We intend to maintain disciplined records of support received and the development activities it helps enable, while protecting confidential know-how and patent-sensitive information.
Use the official EVABIO payment channels shown on this page, not personal payment instructions supplied elsewhere.
Payment confirmations, contribution purpose and related development records should be retained for accounting and governance.
Voluntary support does not by itself create equity, repayment, royalty, licensing, product or IP rights.
Sponsorship, co-development, investment, exclusivity or commercial participation is documented separately before any such rights exist.
Public updates may communicate major milestones while confidential formulations, processing windows and patent-sensitive data remain protected.
No. PoliNb⁴¹ / EVABIO is presented as a private technology-development initiative, not as a tax-exempt charitable organization. We therefore describe these payments as voluntary development support, not as tax-deductible charitable donations.
No automatic equity, ownership, repayment right or financial return is created by a voluntary contribution. Any investment or economic participation requires a separate written agreement.
Yes, but a specific sponsored activity should be documented separately with scope, budget, deliverables, confidentiality and any relevant IP terms.
Yes. In-kind technical contributions may be as valuable as cash and can be structured through the development-partner pathway.
We intend to share appropriate public milestone updates. Confidential formulations, process windows, unpublished data and patent-sensitive information remain protected.
For significant support, sponsorship or any contribution requiring documentation, contact Rafael at rafa@polinb.com or Luis at marques@polinb.com before payment.
Contribute voluntarily. Sponsor a gate. Offer technical capability. Introduce the right partner. Or explore a formal strategic investment.
PoliNb⁴¹ is being developed to create a practical polymer delivery route for niobium. Every meaningful contribution can help fund the experiments, validation and industrial steps required to turn that thesis into a repeatable material platform.
Before a new material can reach resin producers or commercial applications, it must survive a sequence of formulation, processability, repeatability, characterization and scale-up decisions.
Niobium grades, polymer carriers, laboratory consumables, plaques, pellets, retained samples and traceable experimental batches.
Mixing, Banbury/Kneader work, DRAIS validation, milling, extrusion, pelletization, injection and associated process trials.
External testing and analytical work needed to turn observations into reproducible, decision-grade technical evidence.
Documentation, quality logic, pilot planning, manufacturing studies, IP work and the transition toward scalable production.
PoliNb⁴¹ follows a gate-based development philosophy. We avoid scaling prematurely and prioritize the experiments and evidence that determine whether the next step is justified.
Find the maximum controlled loading and the best Therpol / niobium operating window.
Repeat critical formulations with traceable records, retained samples and acceptance criteria.
Prove milling, feeding, extrusion, pelletization and thermoplastic reprocessing.
Characterize defined product-base attributes before broader host-polymer claims are pursued.
Voluntary development support is received through EVABIO entities associated with the PoliNb⁴¹ development program. Please identify the payment as “PoliNb41 Development Support” whenever the payment service allows a memo or note.
For contributions made in Brazil through the official business account.
Scan the official QR code in your eligible U.S. banking app.
For supporters who prefer an international payment platform.
Use the official EVABIO.us / @EVABIO profile or open the direct Venmo code.
Companies, foundations, laboratories and strategic organizations may prefer a documented relationship with scope, deliverables and review criteria.
Fund a defined experimental or validation objective with a mutually agreed scope.
Some of the most valuable support is not cash — it is access to the right capability at the right time.
Equity, debt, licensing, exclusivity, co-development or other economic participation belongs in a separate investment process.
We intend to maintain disciplined records of support received and the development activities it helps enable, while protecting confidential know-how and patent-sensitive information.
Use the official EVABIO payment channels shown on this page, not personal payment instructions supplied elsewhere.
Payment confirmations, contribution purpose and related development records should be retained for accounting and governance.
Voluntary support does not by itself create equity, repayment, royalty, licensing, product or IP rights.
Sponsorship, co-development, investment, exclusivity or commercial participation is documented separately before any such rights exist.
Public updates may communicate major milestones while confidential formulations, processing windows and patent-sensitive data remain protected.
No. PoliNb⁴¹ / EVABIO is presented as a private technology-development initiative, not as a tax-exempt charitable organization. We therefore describe these payments as voluntary development support, not as tax-deductible charitable donations.
No automatic equity, ownership, repayment right or financial return is created by a voluntary contribution. Any investment or economic participation requires a separate written agreement.
Yes, but a specific sponsored activity should be documented separately with scope, budget, deliverables, confidentiality and any relevant IP terms.
Yes. In-kind technical contributions may be as valuable as cash and can be structured through the development-partner pathway.
We intend to share appropriate public milestone updates. Confidential formulations, process windows, unpublished data and patent-sensitive information remain protected.
For significant support, sponsorship or any contribution requiring documentation, contact Rafael at rafa@polinb.com or Luis at marques@polinb.com before payment.
Contribute voluntarily. Sponsor a gate. Offer technical capability. Introduce the right partner. Or explore a formal strategic investment.